These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 10952436)
41. Concurrent chemotherapy and radiotherapy for head and neck cancer. Burri RJ; Lee NY Expert Rev Anticancer Ther; 2009 Mar; 9(3):293-302. PubMed ID: 19275508 [TBL] [Abstract][Full Text] [Related]
42. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Haraf DJ; Rosen FR; Stenson K; Argiris A; Mittal BB; Witt ME; Brockstein BE; List MA; Portugal L; Pelzer H; Weichselbaum RR; Vokes EE Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5936-43. PubMed ID: 14676118 [TBL] [Abstract][Full Text] [Related]
43. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888 [TBL] [Abstract][Full Text] [Related]
44. Modified radical neck dissection and minimal invasive tumor surgery in the middle of split course of concomitant chemoradiotherapy of advanced HNSCC. Schwentner I; Schmutzhard J; Andrle J; Haidenberger A; Thumfart WF; De Vries A; Sprinzl GM Auris Nasus Larynx; 2007 Mar; 34(1):85-9. PubMed ID: 17074457 [TBL] [Abstract][Full Text] [Related]
45. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer. Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033 [TBL] [Abstract][Full Text] [Related]
46. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568 [TBL] [Abstract][Full Text] [Related]
47. The Wayne State University experience with adjuvant chemotherapy of head and neck cancer. al-Sarraf M; Kish JA; Ensley JF Hematol Oncol Clin North Am; 1991 Aug; 5(4):687-700. PubMed ID: 1890060 [TBL] [Abstract][Full Text] [Related]
48. Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus. Hao D; Ritter MA; Oliver T; Browman GP Semin Radiat Oncol; 2006 Jan; 16(1):10-9. PubMed ID: 16378902 [TBL] [Abstract][Full Text] [Related]
49. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512 [TBL] [Abstract][Full Text] [Related]
50. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck. Roman E; Raez LE; Santos ES Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455 [TBL] [Abstract][Full Text] [Related]
51. Combined chemotherapy and radiation in the treatment of locally advanced head and neck cancers. Nguyen NP; Sallah S In Vivo; 2000; 14(1):35-9. PubMed ID: 10757059 [TBL] [Abstract][Full Text] [Related]
52. Update on chemoradiotherapy for head and neck cancer. Argiris A Curr Opin Oncol; 2002 May; 14(3):323-9. PubMed ID: 11981279 [TBL] [Abstract][Full Text] [Related]
53. Postoperative therapy in head and neck cancer: state of the art, risk subset, prognosis and unsolved questions. Denaro N; Russi EG; Adamo V; Colantonio I; Merlano MC Oncology; 2011; 81(1):21-9. PubMed ID: 21912194 [TBL] [Abstract][Full Text] [Related]
54. Chemotherapy of head and neck cancer. LaFollette S; Taylor SG Cancer Chemother Biol Response Modif; 1996; 16():462-73. PubMed ID: 8639394 [No Abstract] [Full Text] [Related]
55. Risk-scoring system for predicting mucositis in patients of head and neck cancer receiving concurrent chemoradiotherapy [rssm-hn]. Suresh AV; Varma PP; Sinha S; Deepika S; Raman R; Srinivasan M; Mandapal T; Reddy CO; Anand BB J Cancer Res Ther; 2010; 6(4):448-51. PubMed ID: 21358078 [TBL] [Abstract][Full Text] [Related]
56. Radiation and chemotherapy as combined treatment for advanced head and neck cancer. Witt ME Medsurg Nurs; 1998 Jun; 7(3):159-64. PubMed ID: 9727134 [TBL] [Abstract][Full Text] [Related]
57. Concomitant radiation and chemotherapy with mitomycin-C in advanced head and neck cancer. Ausili-Cefaro G; Marmiroli L; Salvi G; Nardone L Rays; 1993; 18(3):405-10. PubMed ID: 8284456 [No Abstract] [Full Text] [Related]
58. [Induction chemotherapy for locally advanced head and neck cancer]. Calais G; Chapet S; Ruffier-Loubière A; Bernadou G Cancer Radiother; 2013 Oct; 17(5-6):498-501. PubMed ID: 24011601 [TBL] [Abstract][Full Text] [Related]
59. Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer. Mouw KW; Haraf DJ; Stenson KM; Cohen EE; Xi X; Witt ME; List M; Blair EA; Vokes EE; Salama JK Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1226-34. PubMed ID: 21173372 [TBL] [Abstract][Full Text] [Related]
60. Does response to induction chemotherapy (IC) predict locoregional control after concurrent chemoradiotherapy (CCRT) in locally advanced head and neck cancer (LAHNC)? Cotter R; Blacksburg S; Carpenter T; Kann B; Bakst R; Misiukiewicz K; Posner M; Som P; Gupta V Oral Oncol; 2014 Jun; 50(6):e27-8. PubMed ID: 24680084 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]